- Home
- ORIC vs LOVE Comparison
ORIC vs LOVE Comparison
Compare ORIC & LOVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- LOVE
- Stock Information
- Founded
- ORIC 2014
- LOVE 1998
- Country
- ORIC United States
- LOVE United States
- Employees
- ORIC N/A
- LOVE N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- LOVE Other Specialty Stores
- Sector
- ORIC Health Care
- LOVE Consumer Discretionary
- Exchange
- ORIC Nasdaq
- LOVE Nasdaq
- Market Cap
- ORIC 633.7M
- LOVE 550.8M
- IPO Year
- ORIC 2020
- LOVE 2018
- Fundamental
- Price
- ORIC $8.34
- LOVE $27.13
- Analyst Decision
- ORIC Strong Buy
- LOVE Strong Buy
- Analyst Count
- ORIC 9
- LOVE 5
- Target Price
- ORIC $18.75
- LOVE $38.40
- AVG Volume (30 Days)
- ORIC 294.2K
- LOVE 513.4K
- Earning Date
- ORIC 11-12-2024
- LOVE 12-12-2024
- Dividend Yield
- ORIC N/A
- LOVE N/A
- EPS Growth
- ORIC N/A
- LOVE N/A
- EPS
- ORIC N/A
- LOVE 0.43
- Revenue
- ORIC N/A
- LOVE $689,645,000.00
- Revenue This Year
- ORIC N/A
- LOVE $3.84
- Revenue Next Year
- ORIC N/A
- LOVE $7.02
- P/E Ratio
- ORIC N/A
- LOVE $62.11
- Revenue Growth
- ORIC N/A
- LOVE 0.20
- 52 Week Low
- ORIC $6.33
- LOVE $18.21
- 52 Week High
- ORIC $16.65
- LOVE $39.49
- Technical
- Relative Strength Index (RSI)
- ORIC 37.88
- LOVE 34.61
- Support Level
- ORIC $7.90
- LOVE $25.31
- Resistance Level
- ORIC $8.62
- LOVE $27.36
- Average True Range (ATR)
- ORIC 0.48
- LOVE 1.87
- MACD
- ORIC -0.15
- LOVE -1.53
- Stochastic Oscillator
- ORIC 17.96
- LOVE 16.26
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533.
About LOVE The Lovesac Company
The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.